[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific mRNA Vaccines & Therapeutics Market Report 2017

August 2017 | 111 pages | ID: A27F323D3DBEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific mRNA Vaccines & Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of mRNA Vaccines & Therapeutics for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific mRNA Vaccines & Therapeutics market competition by top manufacturers/players, with mRNA Vaccines & Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Argos Therapeutics
  • AstraZeneca
  • Bayer
  • BioNTech
  • Boehringer Ingelheim
  • CRISPR Therapeutics
  • CureVac
  • eTheRNA immunotherapies
  • Ethris
  • GlaxoSmithKline Vaccines
  • In-Cell-Art
  • Intellia Therapeutics
  • Janssen
  • Kernal Biologics
  • MaxCyte
  • Moderna Therapeutics
  • Novartis
  • PhaseRx
  • Precision NanoSystems
  • RaNa Therapeutics
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Standardization Of Cancer Treatment MRNA Vaccine
  • Individualized Cancer Treatment MRNA Vaccine
  • Infectious Disease Treatment MRNA Vaccine
  • Infection Prevention MRNA Vaccine
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of mRNA Vaccines & Therapeutics for each application, includin
  • Application 1
  • Application 2
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific mRNA Vaccines & Therapeutics Market Report 2017

1 MRNA VACCINES & THERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of mRNA Vaccines & Therapeutics
1.2 Classification of mRNA Vaccines & Therapeutics by Product Category
  1.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Standardization Of Cancer Treatment MRNA Vaccine
  1.2.4 Individualized Cancer Treatment MRNA Vaccine
  1.2.5 Infectious Disease Treatment MRNA Vaccine
  1.2.6 Infection Prevention MRNA Vaccine
1.3 Asia-Pacific mRNA Vaccines & Therapeutics Market by Application/End Users
  1.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.1 Application
  1.3.2 Application
1.4 Asia-Pacific mRNA Vaccines & Therapeutics Market by Region
  1.4.1 Asia-Pacific mRNA Vaccines & Therapeutics Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of mRNA Vaccines & Therapeutics (2012-2022)
  1.5.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC MRNA VACCINES & THERAPEUTICS COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific mRNA Vaccines & Therapeutics Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific mRNA Vaccines & Therapeutics (Volume and Value) by Type
  2.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific mRNA Vaccines & Therapeutics (Volume) by Application
2.4 Asia-Pacific mRNA Vaccines & Therapeutics (Volume and Value) by Region
  2.4.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Region (2012-2017)

3 CHINA MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

3.1 China mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  3.1.1 China mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  3.1.2 China mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
  3.1.3 China mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
3.2 China mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
3.3 China mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

4 JAPAN MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

4.1 Japan mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  4.1.1 Japan mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
  4.1.3 Japan mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
4.2 Japan mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
4.3 Japan mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

5 SOUTH KOREA MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  5.1.1 South Korea mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
5.2 South Korea mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
5.3 South Korea mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

6 TAIWAN MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  6.1.1 Taiwan mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
6.2 Taiwan mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
6.3 Taiwan mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

7 INDIA MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

7.1 India mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  7.1.1 India mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  7.1.2 India mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
  7.1.3 India mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
7.2 India mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
7.3 India mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

8 SOUTHEAST ASIA MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  8.1.1 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
8.2 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
8.3 Southeast Asia mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

9 AUSTRALIA MRNA VACCINES & THERAPEUTICS (VOLUME, VALUE AND SALES PRICE)

9.1 Australia mRNA Vaccines & Therapeutics Sales and Value (2012-2017)
  9.1.1 Australia mRNA Vaccines & Therapeutics Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia mRNA Vaccines & Therapeutics Revenue and Growth Rate (2012-2017)
  9.1.3 Australia mRNA Vaccines & Therapeutics Sales Price Trend (2012-2017)
9.2 Australia mRNA Vaccines & Therapeutics Sales Volume and Market Share by Type
9.3 Australia mRNA Vaccines & Therapeutics Sales Volume and Market Share by Application

10 ASIA-PACIFIC MRNA VACCINES & THERAPEUTICS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Argos Therapeutics
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 AstraZeneca
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 AstraZeneca mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Bayer
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Bayer mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 BioNTech
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Boehringer Ingelheim
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 CRISPR Therapeutics
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 CureVac
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 eTheRNA immunotherapies
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Ethris
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 GlaxoSmithKline Vaccines
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 mRNA Vaccines & Therapeutics Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 In-Cell-Art
10.12 Intellia Therapeutics
10.13 Janssen
10.14 Kernal Biologics
10.15 MaxCyte
10.16 Moderna Therapeutics
10.17 Novartis
10.18 PhaseRx
10.19 Precision NanoSystems
10.20 RaNa Therapeutics

11 MRNA VACCINES & THERAPEUTICS MANUFACTURING COST ANALYSIS

11.1 mRNA Vaccines & Therapeutics Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of mRNA Vaccines & Therapeutics

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 mRNA Vaccines & Therapeutics Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of mRNA Vaccines & Therapeutics Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC MRNA VACCINES & THERAPEUTICS MARKET FORECAST (2017-2022)

15.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific mRNA Vaccines & Therapeutics Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific mRNA Vaccines & Therapeutics Price Forecast by Type (2017-2022)
15.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of mRNA Vaccines & Therapeutics
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Standardization Of Cancer Treatment MRNA Vaccine Product Picture
Figure Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure Infectious Disease Treatment MRNA Vaccine Product Picture
Figure Infection Prevention MRNA Vaccine Product Picture
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of mRNA Vaccines & Therapeutics by Application in 2016
Figure Application 1 Examples
Table Key Downstream Customer in Application
Figure Application 2 Examples
Table Key Downstream Customer in Application
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure India mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Players/Suppliers
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Players
Figure 2017 Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Players
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Type (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Type (2012-2017)
Figure Sales Market Share of mRNA Vaccines & Therapeutics by Type (2012-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Type (2012-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share by Region (2012-2017)
Figure Sales Market Share of mRNA Vaccines & Therapeutics by Region (2012-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region in 2016
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of mRNA Vaccines & Therapeutics by Region (2012-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2016
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2012-2017)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Application (2012-2017)
Figure China mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure China mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
Table China mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
Table China mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
Table China mRNA Vaccines & Therapeutics Sales Volume (K Units) by Applications (2012-2017)
Table China mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure China mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
Figure Japan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
Table Japan mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
Table Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
Table Japan mRNA Vaccines & Therapeutics Sales Volume (K Units) by Applications (2012-2017)
Table Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Japan mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
Figure South Korea mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
Table South Korea mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure South Korea mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
Table South Korea mRNA Vaccines & Therapeutics Sales Volume (K Units) by Applications (2012-2017)
Table South Korea mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure South Korea mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
Figure Taiwan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
Table Taiwan mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Taiwan mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
Table Taiwan mRNA Vaccines & Therapeutics Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Taiwan mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
Figure India mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure India mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure India mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
Table India mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
Table India mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure India mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
Table India mRNA Vaccines & Therapeutics Sales Volume (K Units) by Application (2012-2017)
Table India mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure India mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
Figure Southeast Asia mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
Figure Australia mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Australia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia mRNA Vaccines & Therapeutics Sales Price (USD/Unit) Trend (2012-2017)
Table Australia mRNA Vaccines & Therapeutics Sales Volume (K Units) by Type (2012-2017)
Table Australia mRNA Vaccines & Therapeutics Sales Volume Market Share by Type (2012-2017)
Figure Australia mRNA Vaccines & Therapeutics Sales Volume Market Share by Type in 2016
Table Australia mRNA Vaccines & Therapeutics Sales Volume (K Units) by Applications (2012-2017)
Table Australia mRNA Vaccines & Therapeutics Sales Volume Market Share by Application (2012-2017)
Figure Australia mRNA Vaccines & Therapeutics Sales Volume Market Share by Application in 2016
Table Argos Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Argos Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table AstraZeneca mRNA Vaccines & Therapeutics Basic Information List
Table AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Bayer mRNA Vaccines & Therapeutics Basic Information List
Table Bayer mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Bayer mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table BioNTech mRNA Vaccines & Therapeutics Basic Information List
Table BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure BioNTech mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Basic Information List
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Boehringer Ingelheim mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure CRISPR Therapeutics mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table CureVac mRNA Vaccines & Therapeutics Basic Information List
Table CureVac mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure CureVac mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Basic Information List
Table eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure eTheRNA immunotherapies mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table Ethris mRNA Vaccines & Therapeutics Basic Information List
Table Ethris mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure Ethris mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Basic Information List
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales Market Share in Asia-Pacific (2012-2017)
Figure GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Revenue Market Share in Asia-Pacific (2012-2017)
Table In-Cell-Art mRNA Vaccines & Therapeutics Basic Information List
Table Intellia Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Janssen mRNA Vaccines & Therapeutics Basic Information List
Table Kernal Biologics mRNA Vaccines & Therapeutics Basic Information List
Table MaxCyte mRNA Vaccines & Therapeutics Basic Information List
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Novartis mRNA Vaccines & Therapeutics Basic Information List
Table PhaseRx mRNA Vaccines & Therapeutics Basic Information List
Table Precision NanoSystems mRNA Vaccines & Therapeutics Basic Information List
Table RaNa Therapeutics mRNA Vaccines & Therapeutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of mRNA Vaccines & Therapeutics
Figure Manufacturing Process Analysis of mRNA Vaccines & Therapeutics
Figure mRNA Vaccines & Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of mRNA Vaccines & Therapeutics Major Manufacturers in 2016
Table Major Buyers of mRNA Vaccines & Therapeutics
Table Distributors/Traders List
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region in 2022
Figure China mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia mRNA Vaccines & Therapeutics Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia mRNA Vaccines & Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific mRNA Vaccines & Therapeutics Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific mRNA Vaccines & Therapeutics Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific mRNA Vaccines & Therapeutics Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories